Wrango Launches Outcomes-Driven Healthcare Marketing Platform

Wrango has announced the launch of its new healthcare marketing platform, designed to help pharmaceutical brands and agencies reach verified healthcare professionals (HCPs) and measure campaign impact using real-world medical data.

The platform enables marketers to identify HCP audiences using claims and electronic health record (EHR) data, activate campaigns across multiple ad platforms, and measure results against downstream clinical behaviour. Wrango says the system is designed to replace fragmented marketing infrastructure with a faster, platform-agnostic workflow that supports quicker campaign activation and clearer reporting.

Early testing included campaigns with companies such as Medtronic, where Wrango reported a 25% lift in conversions among a defined Type 1 diabetes audience. According to the company, the platform also allows teams to build verified HCP segments, launch campaigns across existing media stacks, and analyse performance through a single self-serve interface.

The launch comes amid growing industry pressure to improve targeting and relevance. Research from IQVIA found that only 36% of HCPs say most pharmaceutical content they receive is relevant, highlighting ongoing challenges around precision targeting and engagement.

solli’s Final Thoughts 

The launch reflects a broader shift toward outcomes-based measurement in healthcare media. As marketers look to connect media investment with real-world impact, platforms that combine verified HCP audiences with clinical data signals are gaining attention.

For pharma marketers, the next step will be understanding how these systems integrate with existing omnichannel media strategies and measurement frameworks, particularly as the industry moves toward greater accountability in HCP engagement.